Clinical Trial Update: Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the VIM with VIT regimen is underway in children with relapsed and refractory soft tissue sarcoma. The study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• VIM
• VIT

Snippet

Sponsor: Yizhuo Zhang | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING